Overview

Infertility Treatment Market is estimated to value over USD 2.8 billion by 2027 end and register CAGR of over 7.8% during the forecast period 2020-2027.

Increasing incidences of obesity and diabetes, environmental effects like air pollution and changing lifestyle are some integral factors leading to infertility in both women and men. According to the data reported by WHO, over 600 million people are identified as overweight and over 2 million people around the world are diagnosed with obesity. Additionally, workplace stress is another contributing factor for increase in infertility cases.

Hefty investments in research and development has created numerous opportunities for the market to prosper. In a recent study, a female mouse successfully conceives and gave birth to an offspring which was healthy and this was done with a synthetic ovary that was created using a 3D printer. This is considered as a breakthrough research thus leading to eminent infertility treatment for women diagnosed with cancer. One of the co-authors, Alexander Rutz, states that these synthetic ovaries are known as biosynthetic organs as they comprise ovarian cells as well as gelatin. The naturally present ovary was removed and replaced by the biosynthetic ovary so that the mouse shall experience its natural ovulation cycle.

Female infertility treatment segment is projected to account for the largest market share during the forecast period. There has been a rise in the female infertility rates, increasing awareness among women regarding infertility treatments, increase in the number of fertility centres and availability of multiple treatment options are integral factors contributing to the market growth.
Hospitals and surgical clinics segment is expected to exhibit noteworthy growth over the forecast period. Hospitals are firmly bolstered by other departments like neonatal intensive care units. Additionally, hospitals offer a comprehensive maternity treatment even after childbirth. Governmental initiatives to increase the number of multispecialty hospitals with departments to perform infertility treatment procedures like IVF coupled with the increasing number of surgical centres with provisions of surgical procedures for the treatment of infertility is projected to proliferate the market.

Major players included in the Infertility Treatment Market are:

Cook Group Incorporated
Esco Micro Pte. Ltd.
Genea Limited
Hamilton Throne, Ltd.
Ihmedical A/S
Irvine Scientific (A Member of Jx Holdings Group)
IVFTech Aps
Kitazato Corporation
Medgyn Products, Inc.
Rocket Medical PLC
Somatex Medical Technologies GmbH
The Baker Company, Inc.
The Cooper Companies, Inc.
Thermo Fisher Scientific
Vitrolife Ab
Zeiss Group

(Note: The list of the major players will be updated with the latest market scenario and trends)

Infertility Treatment Market

Infertility Treatment Market Segmentation:

By Product

Equipment
Microscopes
Imaging Systems
Sperm Analyzer Systems
Ovum aspiration Pumps
Micromanipulator Systems
Incubators
Gas Analyzers
Laser Systems
Cryo Systems
Media & Consumables
Accessories

By Procedure

In Vitro Fertilization
Artificial Insemination
Intrauterine Insemination
Intracervical Insemination
Intratubal Insemination
Fertility Surgery
Laparoscopy
Hysteroscopy
Myomectomy
Laparotomy
Tubal Ligation Reversal
Varicocelectomy
Microsurgical Reconstruction
Vasovasostomy
Vasoepididymostomy
Others

By Patient Type

Female Infertility Treatment
Male Infertility Treatment

By End User

Fertility Centres
Hospitals and Surgical Clinics
Research Institutes
Cryobanks

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways

Stressful lifestyle and consumption of unhealthy products like tobacco and alcohol are primary reasons of infertility and its soaring rise has increased the demand for market
The high costs of treatments and societal pressures on patients can significantly affect the market growth especially in the developing economies

Objectives of the Study:

To provide with an exhaustive analysis on the shoulder replacement market by product, by procedure, by patient type, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com